Essays about: "“pharmaceutical R D sector”"
Showing result 1 - 5 of 8 essays containing the words “pharmaceutical R D sector”.
-
1. End of a blockbuster? – Preventing evergreening of pharmaceutical patents under EU competition law
University essay from Lunds universitet/Juridiska institutionenAbstract : The pharmaceutical industry is dependent on the granting of patents. Patents make it possible for pharmaceutical companies to invest in the necessary R&D to bring new drugs to the market. This benefits consumers and the health care sector at large. READ MORE
-
2. Coordinating the distribution networks in clinical supply chains A case of AstraZeneca’s pharmaceutical and lab kits networks
University essay from Göteborgs universitet/Graduate SchoolAbstract : Decreasing profits and sharp globalized competition has driven the leading pharmaceutical companies to reduce the expenditures of new drug development by redesigning the clinical logistics processes. Under this context, the study managers of a clinical study of AstraZeneca in cardiovascular sector wanted to investigate the potential coordination of the distribution flows of the pharmaceutical kits and ancillary lab kits to the investigation sites as performed by the two strategic outsourcing partners, Fisher and Covance, respectively. READ MORE
-
3. Definition of Relevant Product Market in Reference to R&D Poles in Pharmaceutical Sector Mergers
University essay from Lunds universitet/Juridiska institutionenAbstract : All competition analysis, including in relation to mergers, begins by defining the relevant market. In sectors where innovation plays a major role, the definition of the relevant market must also take into account the R&D efforts of the merging firms. One field in which R&D poles can be identified early on is the pharmaceutical sector. READ MORE
-
4. The Use and Abuse of Patents – Evergreening in the Pharmaceutical Sector
University essay from Lunds universitet/Juridiska institutionenAbstract : This thesis identifies some of the uncertainties surrounding the application of Article 102 of the Treaty on the Functioning of the European Union (TFEU) to evergreening of pharmaceutical patens. The concept of ever¬greening refers to a multitude of strategies adopted by patent holders with the aim to extend the privileged position that the patentee holds due to this exclusive right. READ MORE
-
5. Growth by Merger - A long-term analysis of GlaxoSmithKline
University essay from Göteborgs universitet/Graduate SchoolAbstract : In the present circumstances, the most debatable issue is Merger & Acquisition (M&A) in the corporate sector. In the recent two decades large number of M&A activity has been experienced by various industries including pharmaceutical industry. M&A is a tool for achieving corporate growth and associated synergies. READ MORE